BAK1 Blocking Peptide
-
Catalog number3031BP-50
-
PricePlease ask
-
Size50 μg
-
-
Antibody TargetBak1
-
AccessionQ16611
-
Gene ID578
-
AppearanceColorless liquid
-
Concentration0.5 mg/ml
-
Formulation50 µg (0.2 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 0.1% BSA and 0.02% thimerosal.
-
Application UsageThe peptide is used for blocking the antibody activity of Bak1 (Cat. # 3031-100). It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30-60 minutes at 37°C.
-
Storage Temp-20 °C
-
Shippinggel pack
-
Shelf Life12 months
-
Western Blot WBVerified
-
HandlingThe peptide solution should be gently mixed before use.
-
Research UseFor Rersearch Use Only! Not to be used in humans.
-
TestYou can block the antibody by the specific target amino acid sequence of peptide.
-
Propertiesblocking peptide
-
DescriptionPeptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.
-
Gene target
-
Gene symbolBAK1
-
Short nameBAK1 Blocking Peptide
-
Techniqueblocking peptide, Blocking, peptide, blocking peptides, Biovision made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
-
Alternative nameB-cellular CLL/lymphoma 2-anta this GO nist/killer 1 inhibiting short protein sequence
-
Alternative techniquecontrol, peptides
-
Alternative to gene targetBCL2-anta this GO nist/killer 1, BAK and BAK-LIKE and BCL2L7 and CDN1, BAK1 and IDBG-82944 and ENSG00000030110 and 578, BH domain binding, Plasma membranes, Bak1 and IDBG-156207 and ENSMUSG00000057789 and 12018, BAK1 and IDBG-629109 and ENSBTAG00000000428 and 514090
-
Gene info
-
Identity
-
Gene
-
Long gene nameBCL2 antagonist/killer 1
-
Synonyms gene
-
Synonyms gene name
- BCL2-antagonist/killer 1
-
Synonyms
-
GenBank acession
-
Locus
-
Discovery year1997-10-09
-
Entrez gene record
-
Pubmed identfication
-
RefSeq identity
-
Classification
- BCL2 family
-
VEGA ID